# Product Validation Study of 2 New Devices, EZ-NG (RightSpot pH Indicator) and EZ-pH (RightLevel pH Indicator)

> **NCT02065661** · — · COMPLETED · sponsor: **Florida Hospital Tampa Bay Division** · enrollment: 30 (actual)

## Conditions studied

- Small Bowel Obstruction
- Colectomy
- Bowel Surgeries

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02065661
- **Lead sponsor:** Florida Hospital Tampa Bay Division
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2011-09
- **Primary completion:** 2013-06
- **Final completion:** 2014-02
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2014-02-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02065661

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02065661, "Product Validation Study of 2 New Devices, EZ-NG (RightSpot pH Indicator) and EZ-pH (RightLevel pH Indicator)". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT02065661. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*